MedPath

Investigation of the auditory pathway in single-sided deaf patients with FDG PET

Conditions
H90.3
H90.4
Sensorineural hearing loss, bilateral
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
Registration Number
DRKS00015477
Lead Sponsor
HNO-Uniklinik Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
13
Inclusion Criteria

asymmetric hearing loss, FDG-PET (FDG=fluorodeoxyglucose) images due to a clinical indication with high quality

Exclusion Criteria

younger than 18 years of age, no asymmetric hearing loss

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PET CT: Glucose metabolism of the primary auditory cortex contralateral to the poorer hearing ear<br>(PET CTs were performed before a cochlea implantation due to clinical reasons)
Secondary Outcome Measures
NameTimeMethod
PET CT: Side comparison of the glucose metabolism of the primary auditory cortex (PET CTs were performed before a cochlea implantation due to clinical reasons)
© Copyright 2025. All Rights Reserved by MedPath